99
Views
11
CrossRef citations to date
0
Altmetric
Review

Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency

Pages 125-133 | Published online: 19 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Igor-Wolfgang Blau, Niall Conlon, Robert Petermann, Nikolai Nikolov & Torben Plesner. (2016) Facilitated subcutaneous immunoglobulin administration (fSCIg): a new treatment option for patients with secondary immune deficiencies. Expert Review of Clinical Immunology 12:7, pages 705-711.
Read now

Articles from other publishers (10)

Namita A. Goyal, Chafic Karam, Kazim A. Sheikh & Mazen M. Dimachkie. (2021) Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy. Muscle & Nerve 64:3, pages 243-254.
Crossref
Johan Prevot & Stephen Jolles. (2020) Global immunoglobulin supply: steaming towards the iceberg?. Current Opinion in Allergy & Clinical Immunology 20:6, pages 557-564.
Crossref
Mikhail A. Rojavin, Hugo Chapdelaine, Michael A. Tortorici, Michaela Praus, Gautam Baheti, Ying Zhang, Jutta Hofmann, Roxane Labrosse, Renée Dicaire & Elie Haddad. (2019) Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency. Clinical Pharmacology in Drug Development 9:6, pages 664-670.
Crossref
Benjamin Martin James Shillitoe & Andrew R. Gennery. (2019) An update on X-Linked agammaglobulinaemia: clinical manifestations and management. Current Opinion in Allergy & Clinical Immunology 19:6, pages 571-577.
Crossref
Ben Shillitoe, Rob Hollingsworth, Mark Foster, Tomaz Garcez, David Guzman, J David Edgar & Matthew Buckland. (2018) Immunoglobulin use in immune deficiency in the UK: a report of the UKPID and National Immunoglobulin Databases. Clinical Medicine 18:5, pages 364-370.
Crossref
Maria Giovanna Danieli, Federica Pulvirenti, Valeria Rocchi, Ramona Morariu & Isabella Quinti. (2016) Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies. Immunotherapy 8:9, pages 995-1002.
Crossref
Johnny S. Salameh, Wissam Deeb, Lauren Burawski, Suzanne Wright & Nizar Souayah. (2016) Safety and Efficacy of Subcutaneous Immunoglobulin in the Treatment of Neuromuscular Disorders. Journal of Clinical Neuromuscular Disease 17:3, pages 110-119.
Crossref
Emily Carne, Mark Ponsford, Tariq El-Shanawany, Paul Williams, Trevor Pickersgill & Stephen Jolles. (2016) Five years of self-administered hyaluronidase facilitated subcutaneous immunoglobulin (fSCIg) home therapy in a patient with primary immunodeficiency. Journal of Clinical Pathology 69:1, pages 87-88.
Crossref
S Jolles, R Borrell, S Zouwail, A Heaps, H Sharp, M Moody, C Selwood, P Williams, C Phillips, K Hood, S Holding & T El Shanawany. (2014) Calculated globulin (CG) as a screening test for antibody deficiency. Clinical and Experimental Immunology 177:3, pages 671-678.
Crossref
Stephen Jolles. (2013) The Variable in Common Variable Immunodeficiency: A Disease of Complex Phenotypes. The Journal of Allergy and Clinical Immunology: In Practice 1:6, pages 545-556.
Crossref